Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Swallowing a lot of minoxidil, a hair growth liquid, can cause severe and long-lasting low blood pressure.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Dried blood spots can be as stable as frozen liquid samples for storing certain metabolites.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Older age increases positive hair alcohol test results, and chest hair is a good alternative for testing; season affects results, with higher levels in winter.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

EtG in hair can help detect alcohol use but may be inaccurate in people with certain health conditions.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Finasteride safely lowers DHT levels without affecting testosterone.

Birth control pills can help reduce mild to moderate acne in women.

Hormonal imbalances can cause acne, and treatments may include hormone-blocking medications.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

Minoxidil controls blood pressure effectively, but may cause side effects like hypertrichosis.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.